Updated September 2026Daily drops, untested in peopleWisp review
A daily sublingual drop at $225 a month, which the seller says has not yet been tested in the human body.
The verdict
Wisp sells compounded semaglutide as a daily sublingual drop at $225 a month for a 28-day bottle. Its own FAQ says the formulation has not yet been tested within the human body. A $99 monthly check-in appears separately in the program FAQ.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide
- Form
- Oral
- From
- From $225/mo
- Dose published
- Yes
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- Availability
- 26 states and DC
Wisp is a telehealth company focused on sexual and reproductive health, with a weight care section. Its GLP-1 is a 15 mL bottle of compounded semaglutide drops, taken under the tongue once daily. The weight care shop page lists no injection and no tirzepatide. The drops are sold for delivery only.
Who writes the prescription, and what do they see?
A provider reviews a medical history submitted through the platform before prescribing. The seller says patients hear from a provider 24 to 72 hours after the consult request. Providers are described as board-certified. One physician, a DO, is named on the weight care team panel. The prescribing clinician for a given patient is not named in advance.
The program FAQ describes a monthly cycle. After three weeks the card is authorized for the check-in, and the provider reviews progress before the refill. The check-in is then charged, together with the medication when delivery is chosen. The same process repeats each month.
What happens when the dose goes up?
The bottle is labeled 0.3 mg to 1.0 mg, a 28-day supply taken once daily. The lowest dose goes into the cart first, and the provider adjusts from there. The directions let the patient self-advance to the next dose if it is tolerated, per the prescription. A price for higher doses is not stated.
What the price includes
The drops are $225 a month, and six months at that rate is $1,350. The weight care FAQ adds a $99 check-in charged each month. The product page does not say whether $225 already includes it. That question is worth settling before the first refill.
What it claims, and what it cites
The drops are compounded by a 503A pharmacy that Wisp does not name. The FAQ states compounded semaglutide is not FDA-approved. No approved semaglutide product is a sublingual drop. The weight-loss trials of semaglutide tested a weekly injection and a daily tablet, so their results were not measured in this form. The seller's absorption data come from lab tests on human-derived tissue.
Where it holds up, and where it does not
- Strength: Seller discloses the drops are untested in people
- Strength: No refrigeration needed for the drops
- Strength: Dose range printed on the product page
- Limitation: No human testing of this formulation
- Limitation: Monthly check-in charge sits beside the price
- Limitation: Served in 26 states and DC
- Limitation: No tirzepatide or injection on the shop page
What the evidence says about this kind of treatment
The assessment above is about Wisp. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who will not inject and accepts a formulation without human data.
- Wrong for
- A reader who wants the form the semaglutide trials actually tested.
How Wisp compares
| Seller | Who it suits | Go |
|---|---|---|
 Revel Health | A reader who wants an oral and expects to pay less for it, which on this seller is what happens. | See Revel Health → |
 Zera Health | A reader who budgets from the monthly rate printed beside the first-month offer. | See Zera Health → |
 HealthSource | Readers who want the compounding source identified and the contents itemized | See HealthSource → |
More GLP-1 telehealth sellers reviews: TeleHealth Weight SolutionsTelePeptideTeleZen MDTelos RxThe Aesthetic ConciergeThe Edit
Sponsored alternative
Bodybuilding Health+
A reader unwilling to prepay a year before seeing how the drug goes
Check Bodybuilding Health+ availability →Frequently asked
- Has this drop been tested in people?
- Not according to Wisp. Its FAQ says lab tests on human-derived tissue suggest absorption, but the formulation has not yet been tested within the human body.
- Is there a charge besides the $225?
- The weight care FAQ describes a $99 monthly check-in. The product page does not say whether $225 already includes it.
- Which states are served?
- Twenty-six states and Washington, D.C., as listed in the product page FAQ.
- Is Wisp legit?
- Wisp is a GLP-1 telehealth sellers service. Its stated availability: 26 states and DC. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Wisp expensive compared with other GLP-1 telehealth sellers?
- Wisp publishes a starting figure of $225/mo. Across the 368 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $449 with a median of $189, which puts Wisp above the median. The other 20 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.